JOURNAL REVIEWED: Ophthalmologica
Latest Contribution
Perspectives on sustainability in ophthalmology
This was a prospective study of a multi-item survey aimed to assess and analyse patients’ perception of sustainability and the role of healthcare in general, and ophthalmology in particular. Levels of agreement were measured using a Likert scale. 105 patients...
Comparison of the efficacy of anti-VEGFs agents in nvAMD
This retrospective multicentric study conducted in Israel and Canada, compared the efficacy of bevacizumab, aflibercept 2mg and ranibizumab as first-line treatments for neovascular age-related macular degeneration (nvAMD). Included were treatment-naïve nvAMD eyes receiving ≥12 months of treat-and-extend (T&E) anti-VEGF therapy...
IVT Aflibercept 2mg in nAMD: XTEND at 3 years
This study investigated the long-term, effectiveness and safety of IVT-AFL 2mg for neovascular age-related macular degeneration (nAMD). XTEND was a multicentre, observational, prospective study, which was conducted across 127 centres across 17 countries with a follow-up period of 36 months....
